The ESTIV Members AreaThe new Biomedical research report from ECVAM is out: https://ec.europa.eu/jrc/en/science-update/tackling-neurodegenerative-diseases-more-human-relevant-research.
3 May 2021
The new Biomedical research report from ECVAM: Tackling neurodegenerative diseases with more human relevant research
Related content
Renewal of the ESTIV Board: Call for Applications
As is customary with any society, the terms of several board members are set to conclude after a certain time. We are now seeking new enthusiastic members who can join our team and help build upon the great work of our colleagues
👨🔬👩🔬 If you are passionate about promoting in vitro and in silico toxicology and contributing to the advancement of the field, we encourage you to apply!
The Latest in Liver Toxicity Assessment In Vitro
We’re excited to announce that registration is now open for the upcoming joint ASCCT-ESTIV webinar titled “The Latest in Liver Toxicity Assessment In Vitro,” which will feature presentations by Magnus Ingelman-Sundberg, PhD, BSc.Med from the Karolinska Institutet, and Mathieu Vinken, PhD, PharmD, ERT from Vrije Universiteit Brussel.
ESTIV Applied training course will be organised on May 29 – June 2 in Bratislava, Slovakia
The training course will be held in Bratislava, Slovakia, from May 29 to June 3, 2023. It is open to toxicologists, risk assessors, and other professionals interested in expanding their knowledge of #invitro and #insilico toxicology. Led by experts in the field, the course will provide you with hands-on training and practical experience that you can apply to your work. Don’t miss this opportunity to learn from the best in the field!
Gold Sponsor
Corporate Members
Memorandum of Understanding
